A new measure of prognostic separation in survival data

Cited by (450)

Items 201–300 of 450

1. Chapter 4: Comorbidities and Current Smoking Status amongst Patients Starting Renal Replacement Therapy in England, Wales and Northern Ireland from 2008 to 2009
   Lynsey Webb, Julie A. Gilg, Terry Feest, Damian G. Fogarty · 2011 · Nephron Clinical Practice
2. Lifestyle modification in older versus younger patients with coronary artery disease
   Patricia Jepma, Harald Thune Jorstad, Marjolein Snaterse, Gerben ter Riet, Hans A. Kragten, Sangeeta Lachman, Madelon Minneboo, S. Matthijs Boekholdt, Ron J.G. Peters, Wilma J.M. Scholte op Reimer · 2020 · Heart
3. Serum free thiols in type 2 diabetes mellitus: A prospective study
   Emmelien E. M. Schillern, Andreas Pasch, Martin Feelisch, Femke Waanders, Steven H. Hendriks, Rik Mencke, Geert Harms, Klaas H. Groenier, Henk J. G. Bilo, Jan‐Luuk Hillebrands et al. · 2019 · Journal of Clinical & Translational Endocrinology
4. Development and Validation of a Model for Predicting Diabetic Nephropathy in Chinese People.
   Dan Dan Miao, Enchun Pan, Qin Zhang, Zhong Ming Sun, Yu Qin, Ming Wu · 2017 · PubMed
5. Uncensoring censored data for machine learning: A likelihood-based approach
   Ivan Štajduhar, Bojana Dalbelo-Bašić · 2012 · Expert Systems with Applications
6. A Donor Quality Index for liver transplantation: development, internal and external validation
   Audrey Winter, Cyrille Féray, Étienne Audureau, Daniel Azoulay, Corinne Antoine, Jean‐Pierre Daurès, Paul Landais · 2018 · Scientific Reports
7. Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study
   Ash Kieran Clift, Professor Gary S. Collins, Simon Lord, Stavros Petrou, David John Dodwell, Michael Brady, Julia Hippisley‐Cox · 2023 · The Lancet Digital Health
8. Blood count derangements after sepsis and association with post-hospital outcomes
   Scott J. Denstaedt, Jennifer Cano, Xiao Qing Wang, John P. Donnelly, Sarah M. Seelye, Hallie C. Prescott · 2023 · Frontiers in Immunology
9. Fundamentals of Clinical Prediction Modeling for the Neurosurgeon
   Hendrik-Jan Mijderwijk, Ewout Willem Steyerberg, Hans‐Jakob Steiger, Igor Fischer, Marcel Alexander Kamp · 2019 · Neurosurgery
10. Recursive Partitioning Analysis of Prognostic Factors for Survival in Patients With Advanced Cancer
    Edward Chow, Mohamed Abdolell, Tony Panzarella, Kristin Harris, Andrea Bezjak, Padraig Richard Warde, Ian F. Tannock · 2008 · International Journal of Radiation Oncology*Biology*Physics
11. A framework for quantifying net benefits of alternative prognostic models
    Eleni Rapsomaniki, Ian R. White, Angela Wood, Simon G. Thompson · 2011 · Statistics in Medicine
12. A Measure of Explained Variation for Event History Data
    Janez Stare, Maja Pohar Perme, Robin Henderson · 2010 · Biometrics
13. Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
    Smith Giri, Binod Dhakal, Natalie S. Callander, Eva Medvedova, Kelly Nicole Godby, Bhagirathbhai Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca Wang Silbermann et al. · 2025 · Blood
14. Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis
    Aëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, Bertrand Dunogué, ALICE BEREZNE, Loı̈c Guillevin, Véronique Le Guern, Pascal Cohen, Benjamin Chaigne, Jonathan London et al. · 2023 · Rheumatology
15. Co-exposure to multiple air pollutants, genetic susceptibility, and the risk of myocardial infarction onset: a cohort analysis of the UK Biobank participants
    Zhou Jiang, Shuo Zhang, Tongyu Gao, Keying Chen, Yuxin Liu, Ying Liu, Ting Wang, Ping Zeng · 2023 · European Journal of Preventive Cardiology
16. Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer® (Pancreas)
    Professor Gary S. Collins, Douglas G. Altman · 2013 · British Journal of General Practice
17. Estimates of stage‐specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma
    Leah Ben‐Porat, Katherine S. Panageas, Christine Hanlon, Ami B. Patel, Allan C. Halpern, Alan N. Houghton, Daniel G. Coit · 2005 · Cancer
18. Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm
    Julia Hippisley‐Cox, Carol A. C. Coupland · 2020 · British Journal of General Practice
19. The Prognostic Value of Eight Comorbidity Indices in Older Patients with Cancer: The ELCAPA Cohort Study
    Florence Canouï‐Poitrine, Lauriane Ségaux, Marc‐Antoine Benderra, Frédégonde About, Christophe Tournigand, Marie Laurent, Philippe Caillet, Étienne Audureau, Émilie Ferrat, Jean‐Léon Lagrange et al. · 2022 · Cancers
20. Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714.
    Edward Chow, J. James, William F. Hartsell, Charles W. Scarantino, Robert Ivker, Mack Roach, John H. Suh, William F. Demas, Andre A. Konski, Deborah Watkins Bruner · 2011 · Europe PMC (PubMed Central)
21. Prediction models for risk classification in cardiovascular disease
    Mario Petretta, Alberto Cuocolo · 2012 · European Journal of Nuclear Medicine and Molecular Imaging
22. Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example
    Klaus‐Jürgen Winzer, Anika Buchholz, Martin Christian Schumacher, Willi Sauerbrei · 2016 · PLoS ONE
23. Mortality in Clostridium difficile infection
    Maxim G. Bloomfield, Andrew Carmichael, Effrossyni Gkrania‐Klotsas · 2013 · European Journal of Gastroenterology & Hepatology
24. Prediction Accuracy Measures for a Nonlinear Model and for Right-Censored Time-to-Event Data
    Gang Li, Xiao-Yan Wang · 2016 · Journal of the American Statistical Association
25. External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry
    Audrey Winter, Cyrille Féray, Étienne Audureau, René Écochard, Christian Jacquelinet, Françoise Roudot‐Thoraval, Christophe Duvoux, Jean‐Pierre Daurès, Paul Landais · 2017 · Liver International
26. Lifestyle index for mortality prediction using multiple ageing cohorts in the USA, UK and Europe
    Jing Liao, Graciela Muniz Terrera, Shaun Scholes, Yuantao Hao, Yu‐Ming Chen · 2018 · Scientific Reports
27. Clinical prediction tools to identify patients at highest risk of myeloma in primary care: a retrospective open cohort study
    Constantinos Koshiaris, Ann Van den Bruel, Brian David Nicholson, Sarah L Lay-Flurrie, Richard F. Hobbs, Jason Lee Oke · 2021 · British Journal of General Practice
28. Identifying women with undetected ovarian cancer: independent and external validation of QCancer®(Ovarian) prediction model
    Professor Gary S. Collins, Douglas G. Altman · 2012 · European Journal of Cancer Care
29. Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa
    Julia K. Rohr, Prudence Ive, Charles Robert Horsburgh, Rebecca H. Berhanu, Kate Shearer, Mhairi Maskew, Lawrence C. Long, Ian Sanne, Jean Bassett, Osman Ebrahim et al. · 2016 · Journal of the International AIDS Society
30. External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland
    Colin R Simpson, Chris Robertson, Steven Kerr, Ting Shi, Eleftheria Vasileiou, Emily Moore, Colin McCowan, Utkarsh Agrawal, Helen Stagg, Rachel Mulholland et al. · 2021 · Thorax
31. Defining Optimum Treatment of Patients With Pancreatic Adenocarcinoma Using Regret-Based Decision Curve Analysis
    Jonathan Matthew Hernandez, Athanasios Tsalatsanis, Leigh Ann Humphries, Branko Miladinović, Benjamin Djulbegović, Vic Velanovich · 2013 · Annals of Surgery
32. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data
    Pichai Raman, Samuel E. Zimmerman, Komal S. Rathi, Laurence de Torrenté, Mahdi Sarmady, Chao Wu, Jeremy N. Leipzig, Deanne M. Taylor, Aydın Tözeren, Jessica C. Mar · 2019 · Cancer Genetics
33. Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
    Shi Chen, Liang Chen, Ardan Muammer Saguner, Kai Chen, Deniz Akdiş, Alessio Gasperetti, Corinna Brunckhorst, Hanwei Tang, Guangran Guo, Man Rao et al. · 2022 · Journal of the American Heart Association
34. Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program
    Junming Han, Xiaolei Guo, Li Zhao, Huan Zhang, Siqi Ma, Yan Li, Deli Zhao, Jialin Wang, Fuzhong Xue · 2023 · JAMA Network Open
35. The utility of long-term blood pressure variability for cardiovascular risk prediction in primary care
    Sarah Stevens, Richard J. McManus, Richard Stevens · 2018 · Journal of Hypertension
36. Individual participant data meta‐analysis for external validation, recalibration, and updating of a flexible parametric prognostic model
    Joie Ensor, Kym I E Snell, Thomas P. A. Debray, Paul C. Lambert, Maxime P. Look, Mamas A. Mamas, Karel G.M. Moons, Richard D Riley · 2021 · Statistics in Medicine
37. Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK.
    Jane Lyons, Vahé Nafilyan, Ashley Akbari, Gareth Ivor Davies, Rowena Griffiths, Ewen Munro Harrison, Julia Hippisley‐Cox, Joe Hollinghurst, Kamlesh K. Khunti, Laura North et al. · 2022 · International Journal for Population Data Science
38. Explaining micro-enterprise survival in rural Vietnam: a multilevel analysis
    Franziska Sohns, Javier Revilla Diez · 2018 · Spatial Economic Analysis
39. Comparing the Ability of Two Comprehensive Clinical Staging Systems to Predict Mortality: EOSS and CMDS
    Keisuke Ejima, Neena Xavier, Tapan S. Mehta · 2020 · Obesity
40. Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center
    Ghassan Al Darazi, Elodie Martin, Jean‐Pierre Delord, Iphigénie Korakis, Sarah Bétrian, Myriam Estrabaut, Muriel Poublanc, Carlos Gomez‐Roca, Thomas Filleron · 2020 · International Journal of Cancer
41. Personalized Model to Predict Keratoconus Progression From Demographic, Topographic, and Genetic Data
    Howard P. Maile, Ji-Peng Olivia Li, Mary D Fortune, Patrick J Royston, Marcello T. Leucci, Ismail Moghul, Anita Szabó, Konstantinos Balaskas, Bruce D. Allan, Alison J. Hardcastle et al. · 2022 · American Journal of Ophthalmology
42. Proposal and Validation of Prognostic Scoring Systems for IgG and IgA Monoclonal Gammopathies of Undetermined Significance
    Francesca Gaia Rossi, Maria Teresa Petrucci, Andrea Guffanti, Luigi Marcheselli, Davide Rossi, Vincenzo Callea, Vincenzo Federico, Marianna De Muro, Alessandra Baraldi, Oreste Villani et al. · 2009 · Clinical Cancer Research
43. Identifying patients with undetected renal tract cancer in primary care: An independent and external validation of QCancer® (Renal) prediction model
    Professor Gary S. Collins, Douglas G. Altman · 2012 · Cancer Epidemiology
44. Prediction errors for state occupation and transition probabilities in multi‐state models
    Cristian Spitoni, Violette Lammens, Hein Putter · 2017 · Biometrical Journal
45. The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival
    Yusuf Karakaş, Ömer Dızdar, Sercan Aksoy, Mutlu Hayran, Kadri Altundağ · 2017 · Clinical Breast Cancer
46. External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
    Hanne Åström, Nelson Ndegwa, Hannes Hagström · 2021 · JHEP Reports
47. Predicting liver-related events in NAFLD: A predictive model
    Luis Calzadilla Bertot, Gary P. Jeffrey, Zhengyi Wang, Yi Huang, George Garas, Michael Wallace, Bastiaan de Boer, Jacob George, Mohammed Eslam, Amy L. Phu et al. · 2023 · Hepatology
48. Flexible parametric survival models built on age-specific antimüllerian hormone percentiles are better predictors of menopause
    Fahimeh Ramezani Tehrani, Mohammad Alì Mansournia, Masoud Solaymani–Dodaran, Ewout Willem Steyerberg, Fereidoun Azizi · 2016 · Menopause The Journal of The North American Menopause Society
49. UK Renal Registry 16th Annual Report: Chapter 5 Comorbidities and Current Smoking Status amongst Patients starting Renal Replacement Therapy in England, Wales and Northern Ireland from 2011 to 2012
    Anirudh Rao, Retha D. Steenkamp, Fergus John Caskey · 2013 · Nephron Clinical Practice
50. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
    Daniel Mankarios, Peter David Baade, Pip Youl, R.H. Mortimer, Adedayo A. Onitilo, Anthony William Russell, Suhail A.R. Doi · 2013 · Endocrine
51. Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure
    Agathe Truchot, Marc Raynaud, Ilkka Helanterä, Olivier Aubert, Nassim Kamar, Gillian Divard, Brad C. Astor, Christophe M. Legendre, Alexandre Hertig, Matthias Büchler et al. · 2024 · Journal of the American Society of Nephrology
52. Comparison of Current Staging Systems and a Novel Staging System for Uterine Leiomyosarcoma
    Robert Lawrence Giuntoli, Collette R. Lessard-Anderson, Melissa A. Gerardi, Christina L. Kushnir, William A. Cliby, Daniel Stewart Metzinger, Bobbie S. Gostout · 2013 · International Journal of Gynecological Cancer
53. Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
    Jacqueline Stephen, Gordon D. Murray, David Cameron, Jeremy St J Thomas, I. H. Kunkler, Wilma J. L. Jack, G.R. Kerr, Tammy Piper, Cassandra L. Brookes, DW Rea et al. · 2014 · British Journal of Cancer
54. External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy
    Young Su Joo, Dong Ki Kim, Chung Hee Baek, Jung Tak Park, Hajeong Lee, Beom Jin Lim, Tae‐Hyun Yoo, Kyung Chul Moon, Ho Jun Chin, Shin‐Wook Kang et al. · 2022 · Kidney Research and Clinical Practice
55. Covariate‐adjusted measures of discrimination for survival data
    White, Ian R., Rapsomaniki, Eleni, for the Emerging Risk Factors Collaboration · 2015 · Biometrical Journal
56. Full Blood Count Trends for Colorectal Cancer Detection in Primary Care: Development and Validation of a Dynamic Prediction Model
    Pradeep Singh Virdee, Julietta Patnick, Peter Watkinson, Tim Holt, Jacqueline Birks · 2022 · Cancers
57. External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
    Shona J. Livingstone, Daniel R. Morales, Jacques Fleuriot, Peter T. Donnan, Bruce Guthrie · 2023 · BMC Cardiovascular Disorders
58. Prediction of fatal and non-fatal cardiovascular events in young and middle-aged healthy workers: The IberScore model
    Carlos Fernández-Labandera, Eva Calvo‐Bonacho, Pedro Valdivielso, L. Quevedo-Aguado, Paloma Martínez-Muñoz, Carlos Catalina-Romero, Luis Miguel Ruilope, Miguel Ángel Sánchez-Chaparro · 2019 · European Journal of Preventive Cardiology
59. Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
    Marios Papasotiriou, Maria J. Stangou, Dimitris Chlorogiannis, Smaragdi Marinaki, Dimitrios Xydakis, Erasmia Sampani, Γεώργιος Λιούλιος, Eleni Kapsia, Synodi Zerbala, Maria Koukoulaki et al. · 2022 · Frontiers in Medicine
60. Prognostic models
    P. M. Rothwell · 2008 · Practical Neurology
61. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years
    Laura Cortesi, Luigi Marcheselli, Valentina Guarneri, Claudia Cirilli, Barbara Braghiroli, Angela Toss, Milena Sant, Guido Ficarra, PierFranco Conte, Massimo Federico · 2012 · International Journal of Cancer
62. Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes
    Sotiris Antoniou, Martina Colicchia, Oliver P. Guttmann, Krishnaraj Sinhji Rathod, Paul Wright, S Fhadil, Charles J. Knight, Ajay Jain, Elliot J. Smith, Anthony Mathur et al. · 2017 · European Heart Journal - Quality of Care and Clinical Outcomes
63. Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment
    Chrianna Bharat, Louisa J Degenhardt, Timothy Dobbins, Sarah Larney, Michael Farrell, Sebastiano Barbieri · 2021 · Drug and Alcohol Dependence
64. Effect of competing mortality risks on predictive performance of the QFracture-2012 risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population
    Shona J. Livingstone, Daniel R. Morales, Megan McMinn, Chima S. Eke, Peter T. Donnan, Bruce Guthrie · 2022 · BMJ Medicine
65. The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models
    Maryam Dosani, Scott K. Tyldesley, Brendan Bakos, Jeremy Hamm, Tim Kong, Sarah J. Lucas, Jordan Wong, Mitchell Liu, Sarah Nicole Hamilton · 2018 · Supportive Care in Cancer
66. A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia
    Peter David Baade, Helen Fowler, Kou Kou, Jeff C. Dunn, Suzanne K. Chambers, Christopher Pyke, Joanne F. Aitken · 2022 · Breast Cancer Research and Treatment
67. Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study
    Sowmya Venkataraghavan, James S. Pankow, Eric Boerwinkle, Myriam Fornage, Elizabeth Selvin, Debashree Ray · 2025 · Diabetologia
68. Evaluating the Prognostic Value of New Cardiovascular Biomarkers
    Angela Wood, Philip Greenland · 2009 · Disease Markers
69. Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer
    Douglas G. Altman · 2007 · Translational medicine series
70. Modelling survival in acute severe illness: Cox versus accelerated failure time models
    John L. Moran, Andrew D. Bersten, P. J. Solomon, Cyrus Edibam, Tamara D Hunt · 2008 · Journal of Evaluation in Clinical Practice
71. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population
    Julia Hippisley‐Cox, Ash Kieran Clift, Carol A. C. Coupland, Ruth H. Keogh, Karla Diaz‐Ordaz, Elizabeth Williamson, Ewen Munro Harrison, Andrew C Hayward, Harry Hemingway, Peter Horby et al. · 2020 · medRxiv
72. Characteristics of young and lower functioning patients following total knee arthroplasty: a retrospective study
    Jesse C. Christensen, Andrew J. Kittelson, Brian J. Loyd, Michael A. Himawan, Charles A. Thigpen, Jennifer E. Stevens‐Lapsley · 2019 · BMC Musculoskeletal Disorders
73. Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma
    Vandana Sandhu, Knut Jørgen Labori, Ayelet Borgida, Ilinca M. Lungu, John M.S. Bartlett, Sara Hafezi‐Bakhtiari, Robert Edward Denroche, Gun Ho Jang, Danielle Pasternack, Faridah Mbabaali et al. · 2019 · JCO Clinical Cancer Informatics
74. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: An analysis based on a Chinese population
    Xi Wang, Fei Wan, Jun Pan, Guanzhen Yu, Ying Chen, Jie‐Jun Wang · 2009 · Journal of Surgical Oncology
75. Prospective construction and validation of a prognostic score to identify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival: The METAL3 Study
    Thomas Filleron, Franck Bonnetain, Julien Mancini, Alejandra Martínez, Henri Hubert Roche, Florence Dalenc · 2014 · Contemporary Clinical Trials
76. Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma
    Naicheng Song, Zhaokai Wang, Quanchao Sun, Gaojie Xin, Zuhuan Yao, Ai Huang, Shijie Xing, Yue Qu, Huan Zhang, Zhihong Huang et al. · 2024 · International Immunopharmacology
77. Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT Study
    Vera Vik Bjarkø, Eirin B. Haug, Arnulf Langhammer, Paz Lopez‐Doriga Ruiz, Sofia Carlsson, Kåre I. Birkeland, Tore Julsrud Berg, Elin Pettersen Sørgjerd, Valeriya Lyssenko, Bjørn Olav Åsvold · 2024 · BMJ Open Diabetes Research & Care
78. The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study
    Rami Aldafas, Yana Vinogradova, Thomas Simon James Crabtree, Jason P. Gordon, ISKANDAR RAUF IDRIS · 2025 · Therapeutic Advances in Endocrinology and Metabolism
79. Chapter 4 Comorbidities and Current Smoking Status amongst Patients starting Renal Replacement Therapy in England, Wales and Northern Ireland from 2009 to 2010
    Catriona Shaw, Lynsey Webb, Anna Maria Casula, Charles Tomson · 2012 · Nephron Clinical Practice
80. Replacing performance status with a simple patient-reported outcome in palliative radiotherapy prognostic modelling
    Daniel Howdon, Wilbert B. van den Hout, Yvette M. van der Linden, Katie L. Spencer · 2022 · Clinical and Translational Radiation Oncology
81. Impacts of Nutlin-3a and exercise on murine double minute 2–enriched glioma treatment
    Yisheng Chen, Zhongcheng Fan, Zhiwen Luo, Xueran Kang, Renwen Wan, Fangqi Li, Weiwei Lin, Zhihua Han, Beijie Qi, Jinrong Lin et al. · 2024 · Neural Regeneration Research
82. Can the validity of a cohort be improved by reweighting based on register data? Evidence from the Swedish MDC study
    Anton Nilsson, Carl Bonander, Ulf Strömberg, Jonas Björk · 2020 · BMC Public Health
83. Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis
    Naoto Fujiwara, Eric Trépo, Indu Raman, Quan‐Zhen Li, Delphine Degré, Thierry Gustot, Christophe Moreno, Yujin Hoshida · 2021 · Clinical Gastroenterology and Hepatology
84. Familial Risk and Its Interaction With Body Mass Index and Physical Activity in Anterior Cruciate Ligament Injury Among First-Degree Relatives: A Population-Based Cohort Study
    Hyeong Sik Ahn, Dae‐Hee Lee, Sayada Zartasha Kazmi, Taeuk Kang, Young Sung Lee, Ryunsu Sung, Jaewoo Cha, Yoon Jung Choi, Gahwi Hong, Hoo Jae Hann et al. · 2021 · The American Journal of Sports Medicine
85. Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction
    Jakob Woerner, Thomas M. Westbrook, Jaehyun Joo, Manu Shivakumar, Rasika Venkatesh, Tess Cherlin, Sang‐Hyuk Jung, Seokho Jeong, Damián Maseda, Michelle L. McKeague et al. · 2025 · medRxiv
86. Quantifying predictive accuracy in survival models
    Lirette, Seth T., Aban, Inmaculada · 2017 · Journal of Nuclear Cardiology
87. Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID ‐ LSM Model
    Luis Calzadilla Bertot, Anna Sòria, Alba Jiménez-Masip, Isabel Serra, Teresa Broquetas, Mercedes Vergara, Adrià Rodríguez-Castellano, Carles Aracil, Cautar El Maimouni, Sergio Muñoz et al. · 2025 · Alimentary Pharmacology & Therapeutics
88. Personalized risk stratification in colorectal cancer via PIANOS system
    Du Cai, Haoning Qi, Qiuxia Yang, Huayu Li, Chenghang Li, Chuling Hu, Baowen Gai, Xu Zhang, Yize Mao, Feng Gao et al. · 2025 · Nature Communications
89. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Translation in to Russian
    Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma, J. P. A. loannidis, Petra Macaskill, Ewout Willem Steyerberg, Andrew Julian Vickers, David F. Ransohoff, Professor Gary S. Collins · 2022 · Digital Diagnostics
90. Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer’s disease: a longitudinal analysis
    Giovanni Carbone, Leonardo Bencivenga, Maria Angela Santoro, Natascia De Lucia, Maria Emiliana Palaia, Erica Ercolano, Francesco Scognamiglio, Paul Edison, Nicola Ferrara, Dino Franco Vitale et al. · 2024 · Frontiers in Endocrinology
91. Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study
    Ashley Kieran Clift, Julia Hippisley‐Cox, David John Dodwell, Simon Lord, Mike Brady, Stavros Petrou, Professor Gary S. Collins · 2022 · BMJ Open
92. Systematic Reviews of Prognostic Factor Studies
    Richard D Riley, Karel G.M. Moons, Douglas G. Altman, Professor Gary S. Collins, Thomas P. A. Debray · 2022 · Wiley eBooks
93. Development and validation of a multivariable mortality risk prediction model for COPD in primary care
    Syed Ahmar Shah, Bright I. Nwaru, Aziz Sheikh, Colin R Simpson, Daniel Kotz · 2022 · npj Primary Care Respiratory Medicine
94. Development and validation of a novel risk prediction algorithm to estimate 10-year risk of oesophageal cancer in primary care: prospective cohort study and evaluation of performance against two other risk prediction models
    Julia Hippisley‐Cox, Xue W. Mei, Rebecca Claire Fitzgerald, Carol A. C. Coupland · 2023 · The Lancet Regional Health - Europe
95. Pilot prognostic model of extremely poor survival among high‐risk hepatocellular carcinoma patients
    Curtis Jackson Wray, John Andrew Harvin, Eric Jay Silberfein, Tien C. Ko, Lillian S. Kao · 2012 · Cancer
96. Added predictive value of omics data: specific issues related to validation illustrated by two case studies
    Riccardo De Bin, Tobias Herold, Anne‐Laure Boulesteix · 2014 · BMC Medical Research Methodology
97. Individualized Prediction of Breast Cancer Survival Using Flexible Parametric Survival Modeling: Analysis of a Hospital-Based National Clinical Cancer Registry
    Donsuk Pongnikorn, Phichayut Phinyo, Jayanton Patumanond, Karnchana Daoprasert, Pachaya Phothong, Boonying Siribumrungwong · 2021 · Cancers
98. Modeling Continuous Non-Linear Data with Lagged Fractional Polynomial Regression
    K.K. Adesanya, Abass Ishola Taiwo, Adebayo Funmi Adedodun, Timothy Olabisi OLATAYO · 2018 · Asian Journal of Applied Sciences
99. More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study
    Raphaëlle Momal, Honghao Li, Paul Trichelair, Michaël G. B. Blum, Félix Balazard · 2023 · Trials
100. Machine learning and statistical models to predict all-cause mortality in type 2 diabetes: Results from the UK Biobank study
     Tingjing Zhang, Mingyu Huang, Liangkai Chen, Yang Xia, Weiqing Min, Shuqiang Jiang · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews